TheraRadar
← Back
Data updated: Mar 29, 2026

Viatris

CardiovascularImmunologyRespiratory
Generics

Viatris is a generic drug manufacturer focused on Cardiovascular, Immunology, Respiratory. Key products include ERMEZA.

1947
Since
366
Drugs
-
Trials
2653
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%
35 drugs Phase 1: 1
Immunology 21%
17 drugs Phase 3: 6 Phase 2: 2 Phase 1: 1
Respiratory 17%
13 drugs Phase 3: 6 Phase 1: 3
Oncology 15%
15 drugs Phase 3: 1
Gastroenterology 15%
15 drugs Phase 1: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...